Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
4.73 %
$ 531 M
Market Cap
-3.27
P/E
CGEM - CHANGE IN WORKING CAPITAL
Change in Working Capital CGEM - Cullinan Oncology, Inc.
-339 K
LAST VALUE
69.06%
2 YEAR CAGR
-14.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR